{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T10:34:28Z","timestamp":1790678068115,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Chungbuk National University Hospital","award":["3-202406001-001"],"award-info":[{"award-number":["3-202406001-001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-12821-x","type":"journal-article","created":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T04:28:38Z","timestamp":1753676918000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Association of pulse pressure with presynaptic dysfunction in older adults with Alzheimer\u2019s disease: a cohort study"],"prefix":"10.1038","volume":"15","author":[{"given":"Nayeong","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geun Hui","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon Hyung","family":"Jung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,28]]},"reference":[{"key":"12821_CR1","doi-asserted-by":"crossref","unstructured":"Alzheimer\u2019s, A. Alzheimer\u2019s disease facts and figures. Alzheimer\u2019s Dement. 13, 325\u2013373 (2017).","DOI":"10.1016\/j.jalz.2017.02.001"},{"key":"12821_CR2","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/s1474-4422(12)70291-0","volume":"12","author":"CR Jack Jr","year":"2013","unstructured":"Jack, C. R. Jr. et al. Tracking pathophysiological processes in Alzheimer\u2019s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 12, 207\u2013216. https:\/\/doi.org\/10.1016\/s1474-4422(12)70291-0 (2013).","journal-title":"Lancet Neurol."},{"key":"12821_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/alzrt98","volume":"4","author":"HC Chui","year":"2012","unstructured":"Chui, H. C., Zheng, L., Reed, B. R., Vinters, H. V. & Mack, W. J. Vascular risk factors and Alzheimer\u2019s disease: are these risk factors for plaques and tangles or for concomitant vascular pathology that increases the likelihood of dementia? An evidence-based review. Alzheimers Res. Ther. 4, 1. https:\/\/doi.org\/10.1186\/alzrt98 (2012).","journal-title":"Alzheimers Res. Ther."},{"key":"12821_CR4","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1001\/jamaneurol.2013.1342","volume":"70","author":"KM Rodrigue","year":"2013","unstructured":"Rodrigue, K. M. et al. Risk factors for \u03b2-amyloid deposition in healthy aging: vascular and genetic effects. JAMA Neurol. 70, 600\u2013606. https:\/\/doi.org\/10.1001\/jamaneurol.2013.1342 (2013).","journal-title":"JAMA Neurol."},{"key":"12821_CR5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/ana.410300410","volume":"30","author":"RD Terry","year":"1991","unstructured":"Terry, R. D. et al. Physical basis of cognitive alterations in Alzheimer\u2019s disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572\u2013580. https:\/\/doi.org\/10.1002\/ana.410300410 (1991).","journal-title":"Ann. Neurol."},{"key":"12821_CR6","doi-asserted-by":"publisher","first-page":"1129036","DOI":"10.3389\/fnsyn.2023.1129036","volume":"15","author":"S Meftah","year":"2023","unstructured":"Meftah, S. & Gan, J. Alzheimer\u2019s disease as a synaptopathy: evidence for dysfunction of synapses during disease progression. Front. Synaptic Neurosci. 15, 1129036. https:\/\/doi.org\/10.3389\/fnsyn.2023.1129036 (2023).","journal-title":"Front. Synaptic Neurosci."},{"key":"12821_CR7","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1001\/jamaneurol.2014.4477","volume":"72","author":"DA Nation","year":"2015","unstructured":"Nation, D. A. et al. Pulse pressure in relation to Tau-Mediated neurodegeneration, cerebral amyloidosis, and progression to dementia in very old adults. JAMA Neurol. 72, 546\u2013553. https:\/\/doi.org\/10.1001\/jamaneurol.2014.4477 (2015).","journal-title":"JAMA Neurol."},{"key":"12821_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.2174\/157015906778520782","volume":"4","author":"JB Denny","year":"2006","unstructured":"Denny, J. B. Molecular mechanisms, biological actions, and neuropharmacology of the growth-associated protein GAP-43. Curr. Neuropharmacol. 4, 293\u2013304. https:\/\/doi.org\/10.2174\/157015906778520782 (2006).","journal-title":"Curr. Neuropharmacol."},{"key":"12821_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jalz.2018.08.006","volume":"15","author":"\u00c5 Sandelius","year":"2019","unstructured":"Sandelius, \u00c5. et al. Elevated CSF GAP-43 is Alzheimer\u2019s disease specific and associated with Tau and amyloid pathology. Alzheimers Dement. 15, 55\u201364. https:\/\/doi.org\/10.1016\/j.jalz.2018.08.006 (2019).","journal-title":"Alzheimers Dement."},{"key":"12821_CR10","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1038\/s41467-023-44374-w","volume":"15","author":"N Franzmeier","year":"2024","unstructured":"Franzmeier, N. et al. Elevated CSF GAP-43 is associated with accelerated Tau accumulation and spread in Alzheimer\u2019s disease. Nat. Commun. 15, 202. https:\/\/doi.org\/10.1038\/s41467-023-44374-w (2024).","journal-title":"Nat. Commun."},{"key":"12821_CR11","doi-asserted-by":"publisher","first-page":"17392","DOI":"10.1038\/s41598-022-20324-2","volume":"12","author":"Q Qiang","year":"2022","unstructured":"Qiang, Q., Skudder-Hill, L., Toyota, T., Wei, W. & Adachi, H. CSF GAP-43 as a biomarker of synaptic dysfunction is associated with Tau pathology in Alzheimer\u2019s disease. Sci. Rep. 12, 17392. https:\/\/doi.org\/10.1038\/s41598-022-20324-2 (2022).","journal-title":"Sci. Rep."},{"key":"12821_CR12","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/ana.26492","volume":"92","author":"G Lan","year":"2022","unstructured":"Lan, G. et al. Association of presynaptic loss with Alzheimer\u2019s disease and cognitive decline. Ann. Neurol. 92, 1001\u20131015. https:\/\/doi.org\/10.1002\/ana.26492 (2022).","journal-title":"Ann. Neurol."},{"key":"12821_CR13","doi-asserted-by":"publisher","first-page":"e275","DOI":"10.1212\/wnl.0000000000201417","volume":"100","author":"A \u00d6hrfelt","year":"2023","unstructured":"\u00d6hrfelt, A. et al. Association of CSF GAP-43 with the rate of cognitive decline and progression to dementia in Amyloid-Positive individuals. Neurology 100, e275\u2013e285. https:\/\/doi.org\/10.1212\/wnl.0000000000201417 (2023).","journal-title":"Neurology"},{"key":"12821_CR14","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1186\/s12883-024-03904-9","volume":"24","author":"A Ariaei","year":"2024","unstructured":"Ariaei, A. et al. Investigating the association between the GAP-43 concentration with diffusion tensor imaging indices in Alzheimer\u2019s dementia continuum. BMC Neurol. 24, 397. https:\/\/doi.org\/10.1186\/s12883-024-03904-9 (2024).","journal-title":"BMC Neurol."},{"key":"12821_CR15","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.3233\/jad-220515","volume":"90","author":"F Roveta","year":"2022","unstructured":"Roveta, F. et al. Synaptic proteins as fluid biomarkers in Alzheimer\u2019s disease: A systematic review and Meta-Analysis. J. Alzheimer\u2019s Dis. 90, 1381\u20131393. https:\/\/doi.org\/10.3233\/jad-220515 (2022).","journal-title":"J. Alzheimer\u2019s Disease"},{"key":"12821_CR16","doi-asserted-by":"publisher","first-page":"1286536","DOI":"10.3389\/fmolb.2024.1286536","volume":"11","author":"G Abdi","year":"2024","unstructured":"Abdi, G. et al. 14-3-3 proteins-a moonlight protein complex with therapeutic potential in neurological disorder: in-depth review with Alzheimer\u2019s disease. Front. Mol. Biosci. 11, 1286536. https:\/\/doi.org\/10.3389\/fmolb.2024.1286536 (2024).","journal-title":"Front. Mol. Biosci."},{"key":"12821_CR17","doi-asserted-by":"publisher","first-page":"669","DOI":"10.3389\/fnins.2020.00669","volume":"14","author":"RA Levin","year":"2020","unstructured":"Levin, R. A., Carnegie, M. H. & Celermajer, D. S. Pulse pressure: an emerging therapeutic target for dementia. Front. Neurosci. 14, 669. https:\/\/doi.org\/10.3389\/fnins.2020.00669 (2020).","journal-title":"Front. Neurosci."},{"key":"12821_CR18","doi-asserted-by":"publisher","unstructured":"Sagare, A. P., Bell, R. D. & Zlokovic, B. V. Neurovascular dysfunction and faulty amyloid \u03b2-peptide clearance in Alzheimer disease. Cold Spring Harb. Perspect. Med. 2 https:\/\/doi.org\/10.1101\/cshperspect.a011452 (2012).","DOI":"10.1101\/cshperspect.a011452"},{"key":"12821_CR19","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.neuron.2008.01.003","volume":"57","author":"BV Zlokovic","year":"2008","unstructured":"Zlokovic, B. V. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57, 178\u2013201. https:\/\/doi.org\/10.1016\/j.neuron.2008.01.003 (2008).","journal-title":"Neuron"},{"key":"12821_CR20","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1016\/j.bbadis.2015.12.016","volume":"1862","author":"AR Nelson","year":"2016","unstructured":"Nelson, A. R., Sweeney, M. D., Sagare, A. P. & Zlokovic, B. V. Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer\u2019s disease. Biochim. Biophys. Acta. 1862, 887\u2013900. https:\/\/doi.org\/10.1016\/j.bbadis.2015.12.016 (2016).","journal-title":"Biochim. Biophys. Acta"},{"key":"12821_CR21","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.pharmthera.2018.11.006","volume":"195","author":"Y Chen","year":"2019","unstructured":"Chen, Y., Fu, A. K. Y. & Ip, N. Y. Synaptic dysfunction in Alzheimer\u2019s disease: mechanisms and therapeutic strategies. Pharmacol. Ther. 195, 186\u2013198. https:\/\/doi.org\/10.1016\/j.pharmthera.2018.11.006 (2019).","journal-title":"Pharmacol. Ther."},{"key":"12821_CR22","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.jalz.2018.08.006","volume":"15","author":"\u00c5 Sandelius","year":"2019","unstructured":"Sandelius, \u00c5. et al. Elevated CSF GAP-43 is Alzheimer\u2019s disease specific and associated with Tau and amyloid pathology. Alzheimer\u2019s Dement. 15, 55\u201364. https:\/\/doi.org\/10.1016\/j.jalz.2018.08.006 (2019).","journal-title":"Alzheimer\u2019s Dement."},{"key":"12821_CR23","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.neuron.2017.07.030","volume":"96","author":"C Iadecola","year":"2017","unstructured":"Iadecola, C. The neurovascular unit coming of age: A journey through neurovascular coupling in health and disease. Neuron 96, 17\u201342. https:\/\/doi.org\/10.1016\/j.neuron.2017.07.030 (2017).","journal-title":"Neuron"},{"key":"12821_CR24","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1093\/ajh\/hpaa001","volume":"33","author":"O de Montgolfier","year":"2020","unstructured":"de Montgolfier, O., Thorin-Trescases, N. & Thorin, E. Pathological continuum from the rise in pulse pressure to impaired neurovascular coupling and cognitive decline. Am. J. Hypertens. 33, 375\u2013390. https:\/\/doi.org\/10.1093\/ajh\/hpaa001 (2020).","journal-title":"Am. J. Hypertens."},{"key":"12821_CR25","doi-asserted-by":"publisher","first-page":"688090","DOI":"10.3389\/fnins.2021.688090","volume":"15","author":"B Hussain","year":"2021","unstructured":"Hussain, B., Fang, C. & Chang, J. Blood-Brain barrier breakdown: an emerging biomarker of cognitive impairment in normal aging and dementia. Front. Neurosci. 15, 688090. https:\/\/doi.org\/10.3389\/fnins.2021.688090 (2021).","journal-title":"Front. Neurosci."},{"key":"12821_CR26","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/nrn1387","volume":"5","author":"C Iadecola","year":"2004","unstructured":"Iadecola, C. Neurovascular regulation in the normal brain and in Alzheimer\u2019s disease. Nat. Rev. Neurosci. 5, 347\u2013360. https:\/\/doi.org\/10.1038\/nrn1387 (2004).","journal-title":"Nat. Rev. Neurosci."},{"key":"12821_CR27","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic, B. V. Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders. Nat. Rev. Neurosci. 12, 723\u2013738. https:\/\/doi.org\/10.1038\/nrn3114 (2011).","journal-title":"Nat. Rev. Neurosci."},{"key":"12821_CR28","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.3233\/jad-161088","volume":"57","author":"E T\u00f6nnies","year":"2017","unstructured":"T\u00f6nnies, E. & Trushina, E. Stress Synaptic dysfunction, and Alzheimer\u2019s disease. J. Alzheimers Dis. 57, 1105\u20131121. https:\/\/doi.org\/10.3233\/jad-161088 (2017).","journal-title":"J. Alzheimers Dis."},{"key":"12821_CR29","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/s1474-4422(15)70016-5","volume":"14","author":"MT Heneka","year":"2015","unstructured":"Heneka, M. T. et al. Neuroinflammation in Alzheimer\u2019s disease. Lancet Neurol. 14, 388\u2013405. https:\/\/doi.org\/10.1016\/s1474-4422(15)70016-5 (2015).","journal-title":"Lancet Neurol."},{"key":"12821_CR30","doi-asserted-by":"publisher","unstructured":"Giorgio, J., Adams, J. N., Maass, A., Jagust, W. J. & Breakspear, M. Amyloid induced hyperexcitability in default mode network drives medial temporal hyperactivity and early tau accumulation. Neuron 112, 676\u2013686  https:\/\/doi.org\/10.1016\/j.neuron.2023.11.014 (2024).","DOI":"10.1016\/j.neuron.2023.11.014"},{"key":"12821_CR31","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.neurobiolaging.2007.07.015","volume":"30","author":"AJ Farrall","year":"2009","unstructured":"Farrall, A. J. & Wardlaw, J. M. Blood-brain barrier: ageing and microvascular disease\u2013systematic review and meta-analysis. Neurobiol. Aging. 30, 337\u2013352. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2007.07.015 (2009).","journal-title":"Neurobiol. Aging"},{"key":"12821_CR32","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1001\/2012.jama.10503","volume":"308","author":"BM Kaess","year":"2012","unstructured":"Kaess, B. M. et al. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA 308, 875\u2013881. https:\/\/doi.org\/10.1001\/2012.jama.10503 (2012).","journal-title":"JAMA"},{"key":"12821_CR33","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1161\/01.HYP.0000168052.00426.65","volume":"46","author":"MF O\u2019Rourke","year":"2005","unstructured":"O\u2019Rourke, M. F. & Safar, M. E. Relationship between aortic stiffening and microvascular disease in brain and kidney. Hypertension 46, 200\u2013204. https:\/\/doi.org\/10.1161\/01.HYP.0000168052.00426.65 (2005).","journal-title":"Hypertension"},{"key":"12821_CR34","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1161\/01.Hyp.0000158268.95012.08","volume":"45","author":"G de Simone","year":"2005","unstructured":"de Simone, G. et al. Is high pulse pressure a marker of preclinical cardiovascular disease? Hypertension 45, 575\u2013579. https:\/\/doi.org\/10.1161\/01.Hyp.0000158268.95012.08 (2005).","journal-title":"Hypertension"},{"key":"12821_CR35","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1212\/01.wnl.0000130531.90205.ef","volume":"63","author":"C DeCarli","year":"2004","unstructured":"DeCarli, C. et al. Memory impairment, but not cerebrovascular disease, predicts progression of MCI to dementia. Neurology 63, 220\u2013227. https:\/\/doi.org\/10.1212\/01.wnl.0000130531.90205.ef (2004).","journal-title":"Neurology"},{"key":"12821_CR36","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1016\/j.jalz.2018.01.010","volume":"14","author":"O Hansson","year":"2018","unstructured":"Hansson, O. et al. CSF biomarkers of Alzheimer\u2019s disease concord with amyloid-beta PET and predict clinical progression: A study of fully automated immunoassays in biofinder and ADNI cohorts. Alzheimers Dement. 14, 1470\u20131481. https:\/\/doi.org\/10.1016\/j.jalz.2018.01.010 (2018).","journal-title":"Alzheimers Dement."},{"key":"12821_CR37","doi-asserted-by":"publisher","unstructured":"Jagust, W. J. et al. The Alzheimer\u2019s Disease : Neuroimaging Initiative 2 PET Core. Alzheimer\u2019s Dement. 11, 757\u2013771.  https:\/\/doi.org\/10.1016\/j.jalz.2015.05.001 (2015).","DOI":"10.1016\/j.jalz.2015.05.001"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12821-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12821-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12821-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T17:02:21Z","timestamp":1753722141000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-12821-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,28]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12821"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-12821-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,28]]},"assertion":[{"value":"7 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"27385"}}